Authors


Nicole Cook, PhD

Latest:

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits

This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.


Launia J. White, BS

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Jiaxiao M. Shi, PhD

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Allan I. Pack, MBChB, PhD

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Ketan Patel
Ketan Patel, MD

Latest:

Contributor: After COVID-19, an AI-Driven Path to Risk-Adjusted Value-Based Care

Artificial intelligence (AI) could help drive accurate and effective risk adjustment in value-based care plans.


George Topalsky, MD

Latest:

Eliminating Defects in Value: Turnaround of an MSSP ACO

A health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.


Shelley-Ann M. Girwar, MSc

Latest:

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.


Matthew W. Reynolds, PhD

Latest:

Combatting COVID-19 With Real-World Evidence

A vaccine isn’t the panacea many assume it will be. Even when it becomes available, the virus won’t go away. Real world evidence will be needed to guide decision making.


Molly Moore Jeffery, PhD, MPP

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.


Akshara Kumar, PharmD

Latest:

Institutional Practices for Charitable Medication Access for Uninsured Patients

Analysis of a patient sample enrolled in charitable care at an academic medical center revealed that chronic medications were variably filled at a significant cost.


Sarah E. Messiah, PhD

Latest:

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.


Fadoua El Moustaid, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Juhi Varshney, MD

Latest:

People Experiencing Homelessness in Miami: Insurance Enrollment Rates, Hypertension Trends

People experiencing homelessness face significant barriers to health care access, leading to higher rates of hypertension even among those with health insurance.


Stephen Lott, PharmD, MS

Latest:

Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management

The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.


Dhruv Chopra, MS

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


Jessica Allegretti, MD, MPH

Latest:

Looking Toward the Future: Management of C. Diff Infection

Closing out their discussion on recurrent clostridium difficile infection management, experts share closing thoughts and hopes for the future.


Elliot B. Tapper, MD

Latest:

Baffled by NAFLD: The Horse Might Be Out of the Barn but Should Not Take Us for a Ride

As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.


Jennifer L. Bright, MPA

Latest:

Overhauling Quality Measurement in the US: Measure What Matters

As the US charts its course through the next political era, it is crucial that we boldly allocate resources and prioritize what truly impacts patients. When faced with complexity, feasibility concerns, or entrenched norms, we must proclaim: “It’s the outcomes, stupid.”


Meena Venkatachalam, MSc

Latest:

Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

Jason Shafrin, PhD, serves as the vice president of Health Economics at PRECISIONheor, and Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.


Alison Galbraith, MD, MPH

Latest:

Impact of the COVID-19 Pandemic on Regular Emergency Department Users

Regular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.


Kaitlyn Bader

Latest:

Addressing the Psychosocial Impacts of Inflammatory Skin Conditions in Patient Care

Lauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to atopic dermatitis, psoriasis, and hidradenitis suppurativa.


Areeba Kara, MD

Latest:

Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery

The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.


Matthew Collins, MD, MBA

Latest:

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.


Claudia Uribe, MD

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Dr Matthew G. Vander Heiden | Image Credit: Koch Institute for Integrative Cancer Research at MIT
Matthew G. Vander Heiden, MD, PhD

Latest:

Breaking Barriers, Fostering Collaboration at AACR Annual Meeting 2025

Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken at this year's American Association for Cancer Research (AACR) Annual Meeting.


Jonathan Arnold, MD, MS, MSE

Latest:

Empiric Segmentation of High-risk Patients: A Structured Literature Review

Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.


Megan Peter, PhD

Latest:

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.


Esra Karslioglu French, MD, MBA

Latest:

The Role of Weight Management and Glycemic Control in the Management of Type 2 Diabetes

Panelists discuss how treating obesity as the root cause can create a "virtuous cycle" where weight loss improves insulin resistance, reduces medication needs, and enables better physical activity, breaking the traditional reactive approach to diabetes management.


Johnie Rose, MD, PhD

Latest:

Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries

Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD, of Case Western Reserve University, acknowledge key limitations of their study and prioritize areas for further research.


Jennifer Baron
Jennifer Baron

Latest:

Contributor: In a Fast-Growing and Competitive Dual-Eligible Market, Trust Will Be a Critical Differentiator

Building trust with patients who are dually eligible for Medicaid and Medicare can help to improve their lives as they navigate receiving care to address their clinical and behavioral health needs.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo